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A B S T R A C T
Nitric oxide (NO) is well established as a regulator of neurogenesis. NO increases the proliferation of neural stem
cells (NSC), and is essential for hippocampal injury-induced neurogenesis following an excitotoxic lesion. One of
the mechanisms underlying non-classical NO cell signaling is protein S-nitrosylation. This post-translational
modification consists in the formation of a nitrosothiol group (R–SNO) in cysteine residues, which can promote
formation of other oxidative modifications in those cysteine residues. S-nitrosylation can regulate many phy-
siological processes, including neuronal plasticity and neurogenesis. In this work, we aimed to identify S-ni-
trosylation targets of NO that could participate in neurogenesis. In NSC, we identified a group of proteins oxi-
datively modified using complementary techniques of thiol redox proteomics. S-nitrosylation of some of these
proteins was confirmed and validated in a seizure mouse model of hippocampal injury and in cultured hippo-
campal stem cells. The identified S-nitrosylated proteins are involved in the ERK/MAPK pathway and may be
important targets of NO to enhance the proliferation of NSC.
1. Introduction
Nitric oxide (NO) is a gaseous free radical, a diffusible molecule that
acts as a cellular messenger, having a crucial role in intercellular
communication and in intracellular signaling in many tissues [1–3],
including in the brain [4]. NO can signal through different ways de-
pending on the available substrates, NO concentration and time of ex-
posure. Classical (involving guanylate cyclase and cGMP production)
and non-classical pathways are described for NO [5]. Non-classical
mechanisms comprise covalent protein post-translational modifications
(PTM) by reactive nitrogen species (RNS) derived from the reaction of
NO with other small molecules. Although there are several RNS-in-
duced PTM, three of them have been more intensively studied: tyrosine
nitration, cysteine glutathionylation and cysteine S-nitrosylation [5].
Among them, protein S-nitrosylation, also called S-nitrosation, is the
formation of a nitrosothiol (R-S-NO) in cysteine residues [6]. In the
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cells, nitrosothiols are unstable, when compared to other PTM, due to
the lability of the bond, the presence of denitrosylases and other re-
ductants, such as ascorbate, and the easy reaction with other thiols,
which can also lead to protein S-glutathionylation, the formation of a
mixed disulfide bond with glutathione [7,8].
Enzymatic catalysis is not strictly necessary for S-nitrosothiol for-
mation and degradation in cell environment, so its specificity and im-
plication in cell signaling bears some properties that make it different
from other signaling PTM such as phosphorylation (reviewed in Refs.
[5,6]). We have proposed S-nitrosylation as a short-range NO-derived
signaling mechanism, suggesting that signaling can be favored in pro-
teins located at a short distance from the sources of NO, namely NOS,
and in proteins interacting with them [7]. S-nitrosylation is highly se-
lective and specific for certain proteins and residues, a fact that can be
explained by 3 main factors: subcellular compartmentalization, site
specificity and denitrosylation specificity [5].
Although S-nitrosylation of some proteins has been recently de-
scribed to be involved in processes in the brain such as synaptic plas-
ticity, neurogenesis and even in some neurodegenerative diseases
[7,9–11], the relevance of S-nitrosylation of many other proteins in
these biological processes is still unknown. Neurogenesis refers to the
formation of new neurons from neural stem cells (NSC), which may
possibly be recruited in the adult brain to give rise to new neuronal cells
after a lesion. In the central nervous system, NSC are found to pro-
liferate lifelong in two main regions: the subventricular zone (SVZ) in
the wall of the lateral ventricles and the subgranular zone (SGZ) of
dentate gyrus (DG) of the hippocampus [12,13]. The role of NO on
neurogenesis has been unraveled in the past 15 years, and a dual role
for NO in neurogenesis has been described: on the one hand, NO im-
pairs neurogenesis in physiological conditions [14–16], while a pro-
neurogenic role for NO was described in the SVZ and in the DG fol-
lowing brain injury such as epileptic seizures or stroke [17–27]. These
studies suggest that NO of inflammatory origin is involved in the in-
crease in neurogenesis observed in the dentate gyrus following a brain
lesion, such as in the case of seizures. We have previously demonstrated
that NO can act, by S-nitrosylation, in p21Ras, activating the ERK/
MAPK pathway involved in the stimulation of NSC proliferation, the
first step of neurogenesis [28]. We now show that NO can produce
relevant cysteine redox PTM in several other targets in NSC that may
also impact on neurogenesis after injury.
We aimed to identify new proteins in NSC that were post-transla-
tionally modified by S-nitrosylation in the presence of the nitrosothiol
S-nitroso-L-cysteine (CysSNO), and in vivo, following seizures. CysSNO
is the S-nitrosylated form of the natural amino acid L-cysteine, and it
can be formed in cells or in the extracellular medium. CysSNO can be
translocated through the plasma membrane by amino acid carriers (in
contrast to S-nitrosoglutathione), so it can transnitrosate intracellular
proteins when added outside of the cells, activating pathways regulated
by S-nitrosylation [6,29,30], as well as S-glutathionylation or other
reversible cysteine oxidations [5,8]. Here we screened cysteine oxida-
tion of NSC proteins following exposure to CysSNO. We identified
several proteins that are oxidatively modified by CysSNO in SVZ-de-
rived NSC cultures. Proteins such as hnRNP K, PCNA, 14-3-3, EF-1β and
PEBP-1 were rapidly S-nitrosylated following exposure to CysSNO.
Moreover, we observed a transient increase in the S-nitrosylation of
some of these proteins in vivo, in a model of excitotoxic lesion. Ad-
ditionally, treatment of hippocampal stem cells with CysSNO increased
the S-nitrosylation of these proteins in a dose-dependent manner. Al-
though a role in neurogenesis has been described for some proteins, the
involvement of others in this process is unknown and our work iden-
tifies new possible targets for NO signaling in NSC.
2. Materials and methods
2.1. Reagents and chemicals
Dulbecco's Modified Eagle's medium (D-MEM)/F-12 with 2 mM
GlutaMAX™-I, Gentamicin, B27, N2, Penicillin-Streptomycin (10,000
U/mL), Hanks' Balanced Salt Solution (HBSS), laminin, BODIPY FL N-
(2-aminoethyl)maleimide Biotin-HPDP, Ultralink immobili neutravidin
resin and bicinchoninic acid (BCA) reagents were purchased from
Thermo Fisher Scientific (Waltham, MA, USA). EGF and bFGF were
from Peprotech (London, UK). Kainic acid (KA) was obtained from
Ocean Produce (Charlottetown, Canada). Horseradish peroxidase con-
jugated anti-mouse, anti-rabbit or anti-goat secondary antibodies were
purchased from Cell Signaling (Danvers, MA, USA), and streptavidin-
peroxidase was from Calbiochem (San Diego, CA, USA). NEM, sodium
ascorbate, DTT, IAM, poly-L-lysine, polyornithine, Ethylenediamine
tetraacetic acid (EDTA), ethylene glycol tetraacetic acid (EGTA), neo-
cuproine, 2-mercaptoethanol, Tween-20 and Triton X-100 were pur-
chased from Sigma Chemical (St Louis, MO, USA). Polyvinylidene di-
fluoride (PVDF) membranes, sodium dodecyl sulfate (SDS), Clarity
Western ECL Substrate, immobilized pH gradient (IPG) strips, ampho-
lytes Bio-Lite 3-10 buffer, and Sypro Ruby were purchased from Bio-
Rad (Hercules, CA, USA). Acrylamide, tetramethylethylenediamine
(TEMED) and molecular ladder were obtained from NZYTech (Lisboa,
Portugal). Proteomics-grade trypsin was from Promega (Madison, WI,
USA). The origins of primary antibodies used in Western blot are listed
in Table 1.
2.2. Animals
C57BL/6 newborn mice and 12-week old male mice were used in
this study. All the animals were kept in our animal facility with food
and water ad libitum in a 12 h dark:light cycle. All experiments were
performed in accordance with European guidelines (2010/63/EU) for
the care and use of laboratory animals, as well as Portuguese law (DL
113/2013). The procedures performed in mice have been reviewed and
approved by the Animal Welfare Body of the Center for Neuroscience
and Cell Biology and have been approved by the Direcção Geral de
Alimentação e Veterinária (reference 0421/000/000/2013).
2.3. Subventricular zone neural stem cell cultures
NSC cultures were obtained from the SVZ of 0-3-days C57BL/6 mice
and maintained as previously described [31–33]. NSC grown as floating
neurospheres in Dulbecco's Modified Eagle's Medium: F-12 nutrient
mixture (D-MEM/F-12 with 2 mM GlutaMAX™-I (L-Ala-L-Gln)), sup-
plemented with 1% B27, 1% antibiotic (10,000 units/ml of penicillin,
10 mg/ml streptomycin), 10 ng/ml EGF and 5 ng/ml basic fibroblast
growth factor (bFGF), were collected and plated for 2-3 days on poly-L-
lysine-coated plates. Then, growth factors were excluded from the
medium and cells were kept in this medium for 24 h before the
Table 1
Primary antibodies used in Western blot, and amount of protein used in as-
corbate-reducing biotin switch for each protein.
Protein Antibody Protein amount (μg)
SVZ HC7 DG
hnRNP K Cell Signaling (1:1000) 750 800 1000
PCNA Santa Cruz Biotechnology (1:500) 750 800 1000
14-3-3 ε Cell Signaling (1:1000) 500 800 1000
14-3-3 Cell Signaling (1:1000) 750 – 1000
EF-1β Santa Cruz Biotechnology (1:500) 500 800 1000
PEBP-1 Abcam (1:5000) 750 800 1000
HSPA4 Abcam (1:5000) 500 – –
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experiments.
2.4. Hippocampal stem cell cultures
HC7 cells were kindly provided by Dr. Fred H. Gage (The Salk
Institute for Biological Studies, USA) and maintained as previously
described [34,35]. Briefly, cells were plated on polyornithine (10 μg/
ml) and laminin (10 μg/ml)-coated 60 mm tissue culture dishes in
DMEM/F-12 with 2 mM GlutaMAX-I containing 1% N2 supplement,
20 ng/ml bFGF and 1% of penicillin/streptomycin. Cells were cultured
at 37 °C in 5% C02/95% air and medium was changed every 3-4 days.
For passaging, confluent cells were resuspended in DMEM/F12 with
GlutaMAX complete medium and passaged onto polyornithine/laminin-
coated 100 mm dishes using a split ratio of 1:3. Before the experiments,
cells were kept in medium without bFGF for 24 h.
2.5. Cell treatment
For the assessment of oxidation/S-nitrosylation, SVZ-derived NSC
were treated for 15 min with 100 μM CysSNO. Hippocampal stem cells
were exposed during 15 min to 10, 50 and 100 μM CysSNO for eva-
luation of S-nitrosylation.
2.6. Preparation of CysSNO
CysSNO was prepared as previously described [36,37]. Briefly,
200 mM of L-Cys was prepared in 1 ml of 1 M HCl and added to a
solution of 200 mM NaNO2 in water (1 ml). After 30 min at RT, 2 ml of
1 M potassium phosphate buffer, pH 7.4, were added. The final solution
was divided in several aliquots and stored at -80 °C. CysSNO con-
centration was determined by spectrophotometric analysis at 338 nm in
Nanodrop (Thermo Scientific), using the extinction coefficient of Cy-
sSNO (ε338 = 900 M-1 cm-1) [38]. During the entire protocol, solutions
were kept protected from light, as nitrosothiols are decomposed by
light. The yield of the reaction was around 80%.
2.7. Cell lysates for redox fluorescence switch assay and biotin switch assay
Cells were washed with cold saline physiological solution (0.9%
NaCl, pH 7.4) and then scraped and lysed in TENT pH 6.0 (50 mM Tris-
HCl, 1 mM EDTA, 0.1 mM neocuproine, 1% Triton X-100) supple-
mented with 50 mM NEM to block the free thiols, and protease in-
hibitors (freshly added), protected from light. Four 2-s sonication cycles
were applied. To complete the blocking reaction, 2% SDS was added to
the lysate and incubated 30 min at 37 °C. Protein concentration was
determined by the BCA method, following the manufacturer's instruc-
tions.
2.8. Redox fluorescence switch (RFS) assay
The RFS protocol was adapted from Refs. [37,39]. In order to assess
protein cysteine reversible oxidation, 100 μg of protein were used for 1-
DE gels and 200 μg for 2-DE gels. Protein was precipitated with acetone:
addition of 3 volumes of cold acetone, incubation for 10 min at -20 °C,
followed by centrifugation for 5 min at 12.000 rpm, 4 °C; then the
supernatant was discarded and the process was repeated with 1 volume
of cold acetone. The pellet was resuspended in TENS pH 7.2 (50 mM
Tris-HCl, 1 mM EDTA, 0.1 mM neocuproine, 1% SDS; 100 μl per 50 μg
of protein) with 2.5 mM DTT, to reduce reversibly oxidized thiols.
Following an incubation of 10 min at RT, protein was precipitated with
acetone as before and the pellet was resuspended in TENS pH 7.2 plus
40 μM BODIPY FL N-(2-aminoethyl)maleimide. Following 1 h of in-
cubation, the labeling reaction was stopped by adding 2.5 mM DTT and
protein was precipitated as before. Samples were protected from light
during the entire procedure.
2.9. Protein electrophoresis with fluorescent detection (1-DE and 2-DE)
Following RFS technique, protein samples were separated by 1-DE
(SDS-PAGE) or 2-DE, and then stained with Sypro Ruby, as previously
described [37,39,40].
2.10. 2-DE analysis
2-DE spots’ pattern was analyzed with the PD Quest 2-D analysis
software (Bio-Rad Laboratories). At least four independent experiments
per condition were analyzed. An initial analysis was performed by using
RFS images of each condition (Control and CysSNO-treated samples)
and the same spots were matched in a single gel set and quantified.
Spots were selected when the fluorescence signal was at least two-fold
higher in CysSNO vs. control conditions in at least two replicates. For
several spots, no signal was detected in the control conditions, or it was
much lower than in CysSNO-treated samples. A quantitative analysis
was performed in the remaining spots, calculating the mean
CysSNO:Control ratio in each experiment, and significant differences
were determined using an ANOVA test. Images of the total protein
signal for each gel were matched in a separate gel set and quantified.
The spots selected from the RFS analysis were manually matched to
their corresponding total protein signal spots, and only those in which
the amount of total protein remained constant were finally selected for
identification.
2.11. Mass spectrometry analysis
The spots pinpointing differences in RFS signal that did not corre-
spond to differences in the total protein amount in the 2-DE were
picked, digested and analyzed by MS in the Proteomics Unit of the
CBMSO or in the Proteomics Unit of the CNB (both members of
ProteoRed-ISCIII in Madrid, Spain), as detailed below.
2.12. In-gel digestion
After drying, gel spots were destained in acetonitrile:water (1:1) and
digested in situ with sequencing grade trypsin (Promega, Madison, WI)
as described previously [41] with minor modifications [42]. The gel
pieces were shrunk by removing all liquid using sufficient acetonitrile.
Acetonitrile was pipetted out and the gel pieces were dried in a
speedvac (Eppendorf, Hamburg, Germany). The dried gel pieces were
re-swollen in 50 mM ammonium bicarbonate pH 8.8 with 12.5 ng/μl
trypsin for 1 h in an ice-bath. The digestion buffer was removed, and
gels were covered again with 50 mM ammonium bicarbonate pH 8.8
and incubated at 37 °C for 12 h. Digestion was stopped by the addition
of 1% trifluoroacetic acid. Whole supernatants were dried down and
then desalted onto ZipTip C18 Pipette tips (Millipore) until the mass
spectrometric analysis.
2.13. Protein identification by MALDI-TOF peptide mass fingerprinting
(PMF)
PMF was performed at the Proteomics Unit of the Centro Nacional
de Biotecnología (CNB) in Madrid (Spain). The Proteomics Unit is part
of ProteoRed-ISCIII and PRB3 (Spanish platforms financed by the
ISCIII).
For MALDI-TOF/TOF analysis, 20% of peptide mixture was de-
posited onto a 384-well OptiTOF Plate (AB SCIEX, Foster City, CA) and
allowed to dry at room temperature. A 0.8 μl aliquot of matrix solution
(3 mg/mL α-cyano-4-hydroxycinnamic acid in MALDI solution) was
then deposited onto dried digest and allowed to dry at room tempera-
ture.
Samples in the OptiTOF plate were automatically acquired in an ABi
4800 MALDI TOF/TOF mass spectrometer (AB SCIEX, Foster City, CA)
in positive ion reflector mode (the ion acceleration voltage was 25 kV to
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MS acquisition and 2 kV to MS/MS) and the obtained spectra were
stored into the ABi 4000 Series Explorer Spot Set Manager. PMF and
MS/MS fragment ion spectra were smoothed and corrected to zero
baseline using routines embedded in ABi 4000 Series Explorer Software
v3.6. Each PMF spectrum was internally calibrated with the mass sig-
nals of trypsin autolysis ions to reach a typical mass measurement ac-
curacy of< 25 ppm. Known trypsin and keratin mass signals, as well as
potential sodium and potassium adducts (+21 Da and +39 Da) were
removed from the peak list. To submit the combined PMF and MS/MS
data to MASCOT software v.2.5.0.0 (Matrix Science, London, UK), GPS
Explorer v4.9 was used, searching in the Mus musculus Uniprot protein
database (v20150210: 16706 sequences; 195014757 residues). The
following search parameters were used: enzyme, trypsin; allowed
missed cleavages, 1; carbamidomethyl and maleimide in cysteine and
oxidation of methionine as variable modifications; mass tolerance for
precursors was set to± 40 ppm and for MS/MS fragment ions
to± 0.3 Da. The confidence interval for protein identification was set
to ≥95% (p < 0.05) and only peptides with an individual ion score
above the identity threshold were considered correctly identified.
2.14. Reverse phase-liquid chromatography-tandem mass spectrometry
assay (RP-LC-MS/MS) in selected MS/MS ion monitoring (SMIM) mode
The desalted protein digest was dried, resuspended in 10 μl of 0.1%
formic acid and analyzed by RP-LC-MS/MS in an Easy-nLC II system
coupled to an ion trap LTQ-Orbitrap-Velos-Pro mass spectrometer
(Thermo Scientific). The peptides were concentrated (on-line) by re-
verse phase chromatography using a 0.1 mm × 20 mm Acclaim
PepMap C18 precolumn (5 μm, 100 Å; Thermo Scientific), and then
separated using a 0.075 mm × 25 cm Acclaim PepMap C18 column
(3 μm, 100 Å; Thermo Scientific) operating at 0.3 μl/min. Peptides were
eluted using a 60-min gradient from 5 to 40% solvent B (Solvent A:
0,1% formic acid in water, solvent B: 0,1% formic acid, 80% acetoni-
trile in water). ESI was done using a Nano-bore emitters Stainless Steel
ID 30 μm (Proxeon) interface [42].
The Orbitrap resolution was set at 30.000. Peptides were detected in
survey scans from 400 to 1600 amu (1 μscan), followed by SMIM events
when necessary (the number of events depends on the peptides to be
monitored) plus ten data-dependent MS/MS scans, using an isolation
width of 2 u (in mass-to-charge ratio units), normalized collision energy
of 35%, and dynamic exclusion applied during 30 s periods. In the
SMIM mode [43], used to find peptides in a directed way, the LTQ-
Orbitrap-Velos-Pro detector was programmed to perform, along the
same entire gradient, a continuous sequential operation in the MS/MS
mode on the doubly or triply charged ions corresponding to the peptide
(s) selected previously from the theoretical prediction.
Peptide identification from raw data was carried out using the
SEQUEST algorithm integrated in the Proteome Discoverer 1.4 software
(Thermo Scientific). Database search was performed against a hand-
made database including the proteins of interest. The following con-
straints were used for the searches: tryptic cleavage after Arg and Lys,
up to two missed cleavage sites, and tolerances of 20 ppm for precursor
ions and 0.8 Da for MS/MS fragment ions, and the searches were per-
formed allowing optional Met oxidation, Cys carbamidomethylation
and Cys NEM modification. Search against decoy database (integrated
decoy approach) using false discovery rate < 0.01.
To confirm the identification of peptides monitored, the MS/MS
spectra were manually analyzed by assigning the fragments to the
candidate sequence, after calculating the series of theoretical frag-
mentations, according to the nomenclature of the series as previously
described [44].
2.15. Administration of kainic acid (KA) in a temporal lobe epilepsy mouse
model
Adult male wild-type C57BL/6 with 12 weeks of age were treated
with KA solution injected subcutaneously (25 mg/kg) and the re-
spective controls were treated with a sterile saline solution (0.9% NaCl
in water, pH 7.4), as previously described [23,25]. The weight of the
animals varied between 20 and 30 g. All animals that received KA
developed grade five seizures or higher in the 1972's Racine's six-point
scale modified for mice [45]. In animals injected with saline solution
alone, no seizures were observed and were used as controls. The mice
were maintained for 1, 2, 3 and 5 days after the first generalized sei-
zure. At least three animals survived in each experimental group.
2.16. Dissection of the dentate gyrus and lysates
Animals were sacrificed by cervical dislocation 1, 2, 3 or 5 days
following treatment (saline solution or KA solution). The brains were
removed from the skull following decapitation and placed in a plate
dish containing HBSS medium. Following dissection, the DG of each
animal was mechanically lysed with a tissue homogenizer in TENT pH
6.0 (50 mM Tris-HCl, 1 mM EDTA, 0.1 mM Neocuproine, 0.5% Triton
X-100, pH 6.0) supplemented with 50 mM NEM to block the free thiols,
and protease inhibitors (Roche cOmplete mini, freshly added). Four 2-s
sonication cycles were applied. 2% SDS was added to the lysate and
incubated 30 min at 37 °C to complete the blocking reaction. Protein
concentration was determined by the BCA method.
2.17. Biotin switch assay and Western blot analysis
Determination of S-nitrosylation by the biotin switch assay and of
reversible Cys oxidation by the redox biotin switch assay was per-
formed as described in Refs. [36,37,39], both in dentate gyri samples
(DG extracts) and in cell lysates after thiol blocking, using different
amounts of protein as stated in Table 1.
Lysates were precipitated with acetone and the pellets were re-
suspended in TENS pH 7.2 (50 mM Tris-HCl, 1 mM EDTA, 0.1 mM
neocuproine, 1% SDS, pH 7.2). For DTT reduction, 2.5 mM DTT was
added, and the samples incubated for 10 min at RT; after that, it was
precipitated with acetone, resuspended in TENS pH 7.2 and the reduced
thiols were labeled with 1 mM biotin-HPDP for 1 h. For nitrosothiol
reduction, 100 mM sodium ascorbate and 1 mM biotin-HPDP were
added at the same time, and incubated for 1 h at RT. Until this point all
operations were carried out in the dark. Samples were then precipitated
with acetone and resuspended in HENS (250 mM Hepes pH 7.7, 1 mM
EDTA, 0.1 mM neocuproine, 1% SDS) and then a neutralization buffer
(20 mM Hepes pH 7.7, 1 mM EDTA, 100 mM NaCl, 0.5% Triton) was
added, followed by centrifugation at 13.400 rpm for 1 min. 100 μl of
the supernatant were saved as the Input fraction (total protein), and the
rest was added to the pre-equilibrated Ultralink immobilized neu-
travidin resin. Samples were incubated with the resin for 1 h at RT with
agitation. Following centrifugation (1 min, 2.000 rpm), supernatant
was collected as the non-retained fraction (NR). After washing, 100 μl
of elution buffer were added (20 mM Hepes pH 7.7, 100 mM NaCl,
1 mM EDTA, 100 mM 2-mercaptoethanol) and incubated 20 min at
37 °C for elution of the proteins that bound to the resin. Then, the
mixture was centrifuged for 1 min at 14.500 rpm and the supernatant
was saved as the Eluted Fraction (Oxidized/SNO proteins).
For analysis of specific proteins by Western blot, the eluted fraction
and respective input samples were denatured at 96 °C for 5 min with a
reducing Laemlli buffer and then subjected to an electrophoresis in 12%
SDS/PAGE gels, transferred to PVDF membranes, blocked with 5% low-
fat dry milk or 3% BSA in TBS-T, as appropriated, and then incubated
with the primary antibodies (Table 1) in 1% blocking solution over-
night, at 4 °C. Incubation with the HRP secondary anti-mouse, anti-
rabbit or anti-goat antibodies conjugates (1:2000 in 1% blocking solu-
tion) was performed at RT for 1 h. After that, membranes were in-
cubated with the Clarity Western ECL Substrate (Bio-Rad, Hercules, CA,
USA), and immunoreactive bands were visualized in the Molecular
Imager® ChemiDocTM XRS + Imaging System (Bio-Rad, Hercules, CA,
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USA). Image bands were analyzed with the ImageLab software version
5.1 (Bio-Rad Laboratories, Hercules, CA, USA).
2.18. Data analysis
Data are expressed as means ± SEM. Statistical significance was
determined by using t-test for comparison of two population means or
one-way or two-way analysis of variance (ANOVA) followed by
Bonferroni's or Dunnett's post-tests for comparisons of multiple groups,
as appropriate and indicated in the figure legends and in the text.
Differences were considered significant when p < 0.05. The software
used was GraphPad Prism 5.0 (GraphPad Software, La Jolla, CA, USA).
3. Results
3.1. Identification of proteins oxidized in NSC treated with CysSNO
S-nitrosylation can lead to formation of other cysteine oxidative
PTM such as S-glutathionylation [8]. Thus, a useful method for
screening S-nitrosylation is to assess reversible cysteine oxidation by
RFS, because DTT reduction (which allows to label all reversible cy-
steine oxidations) is more efficient than ascorbate reduction (specific
for S-nitrosylation), providing a higher sensitivity to the method. To
assess reversible oxidative modification of proteins following exposure
to NO and RNS, NSC derived from the SVZ were treated with the ni-
trosothiol CysSNO, and a proper control, without treatment, was used.
Protein oxidation was assessed by the RFS technique followed by 1-
DE or 2-DE. We observed an increase in the global Bodipy-FL signal,
which measures the extent of protein oxidation, following exposure to
CysSNO (Fig. 1A, left panel), and more specifically in some bands. This
effect did not correspond to an increase in the protein amount as no
differences in the Sypro Ruby signal were observed (Fig. 1A, middle
panel). Furthermore, without the reduction step with DTT (negative
control), no Bodipy-FL signal was observed, thus showing the good
specificity of the technique. Merging both signals (Fig. 1A, right panel)
allows a clearer visualization of the differences in oxidation signal be-
tween samples.
To determine which proteins exhibit differential cysteine oxidation
following exposure to CysSNO, RFS samples were run by 2-DE. The
overall pattern of 2-DE spots of CysSNO-treated samples was similar to
that observed in control samples, although there were differences in
some specific spots (Fig. 1B, left panels in green). The observed dif-
ferences reflected an increase in the Bodipy-FL signal in CysSNO-treated
samples, when compared with untreated samples, or even the presence
of a spot that was not detected in control samples. Furthermore, no
differences in total protein signal (Sypro Ruby) were observed (Fig. 1B,
middle panels in red). By merging both signals (Fig. 1B, right panels) a
significant overlapping of the signal corresponding to the same spots
was detected.
To perform a full analysis of the spots of the 2-DE gels and pinpoint
differences in their oxidative signal that did not correspond to differ-
ences in total protein, eight replicates of CysSNO-treated samples where
compared to untreated samples (control) using the PD-Quest 2-DE
analysis software (Bio-Rad Laboratories). Spots were first selected when
the oxidation signal in CysSNO-treated conditions was at least 2-fold
higher than control in at least two replicates. For some of these spots,
qualitative differences were clear, as there was no RFS signal in the
control gel for some replicates or, when present, it was more than 2-fold
smaller (Table 2). For other spots, the RFS spot was clear in most of the
replicate gels of CysSNO-treated samples, and a statistical analysis was
performed so that spots with a p lower than 0.05 were selected
(Table 3). The selected RFS spots were matched to the corresponding
spots of total protein signal (Fig. 2) in the same gels to ensure that they
displayed a constant signal. All the selected spots were manually ex-
cised from at least two replicates of the gels and digested with trypsin.
The resulting peptides were analyzed by MALDI-TOF/TOF and peptide
mass fingerprinting. Eleven different proteins were identified from
these spots (Tables 2 and 3).
The Bodipy-FL label incorporated in the RFS does not allow to lo-
calize which Cys residues are modified, since it alters the fragmentation
Fig. 1. CysSNO increases cysteine oxidation in NSC. Cysteine oxidation of general proteins was assessed by a RFS followed by 1-DE (A) or 2-DE (B) of untreated
NSC, or treated with 100 μM CysSNO for 15 min. A negative control, without DTT, was performed in (A). Oxidation signal is shown by Bodipy-FL labeling (green) and
total protein was stained with Sypro Ruby (red). Some differences in the RFS signal of CysSNO treated cells are shown by the white arrows. Representative images of
8 experiments are shown. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
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pattern of the peptides (Martínez-Ruiz et al., unpublished observa-
tions). To determine the modified Cys residues, the NEM-blocked
samples were labeled with IAM after DTT reduction and separated in
parallel 2-DE gels [37,39]. The spots corresponding to the ones in
which differentially oxidized proteins had been identified were cut and
digested with trypsin. Targeted LC-MS/MS analysis was performed in
an LTQ-VelosPro-orbitrap mass spectrometer, allowing the identifica-
tion of a number of peptides containing IAM-modified Cys residues,
which corresponded to the oxidized Cys (presented in Table 2).
3.2. Confirmation of oxidized and S-nitrosylated proteins in SVZ-derived
NSC
Following extensive analysis of the up-to-date known functions of
the identified proteins, including their role in pathways involved in
neurogenesis and cell proliferation, some of the identified proteins were
selected for further validation of protein oxidation and, more specifi-
cally, S-nitrosylation, following exposure to CysSNO. The confirmation
of the oxidation of individual proteins was achieved by using a redox
biotin switch method [37]. SVZ-derived NSC were exposed to 100 μM
CysSNO for 15 min. Oxidation of the following proteins was identified
following exposure to CysSNO: hnRNP K, PCNA, 14-3-3 proteins (and
specifically 14-3-3 ε), EF-1β, PEBP-1, HSPA4, and hnRNP H (Fig. 3A).
In order to confirm that the identified proteins are, in fact, S-ni-
trosylated in the same conditions, S-nitrosylation was assessed by the
ascorbate-reducing biotin switch assay [37], using antibodies that
specifically detect each protein. S-nitrosylation of the majority of the
proteins mentioned above (hnRNP K, PCNA, 14-3-3,14-3-3 ε, EF-1β and
PEBP-1) was detected following exposure to 100 μM CysSNO for
15 min, when compared to control samples (Fig. 3B). S-nitrosylation of
HSPA4 was not observed using up to 750 μg of protein in cell lysate,
after treatment with CysSNO (Fig. 3B), and this target was not further
pursued.
3.3. Validation of S-nitrosylated proteins in the dentate gyrus after seizures
To investigate whether S-nitrosylation of the identified proteins was
relevant in NSC after brain injury, we used an excitotoxic lesion mouse
model that is characterized by an increase in neurogenesis in the DG
after induction of seizures with kainic acid (KA) [23,25]. S-nitrosylation
of proteins was assessed by ascorbate-reducing biotin switch 1, 2, 3 and
5 days after KA treatment, so we could also evaluate the kinetics of
modification of each protein.
Of the analyzed proteins, we observed S-nitrosylation of hnRNP K,
14-3-3, 14-3-3 ε and PEBP-1, but not of PCNA or EF-1β (Fig. 4A).
hnRNP K S-nitrosylation significantly increased 2 days after KA treat-
ment (195.5 ± 45.0%, p < 0.05, Fig. 4B), comparing with control. 1,
3 and 5 days after KA treatment, S-nitrosylation of hnRNP K was similar
to control. S-nitrosylation of all 14-3-3 proteins isoforms significantly
increased 1 day after KA treatment (149.9 ± 34.8%, p < 0.05,
Fig. 4B), and was similar to control 2, 3 and 5 days after seizure onset.
S-nitrosylation of 14-3-3 ε, the most interesting isoform regarding
neurogenesis, showed a tendency to increase 1 and 2 days after KA
treatment (p > 0.05 not significant, Fig. 4B) and to be maintained or
diminished after 3 and 5 days, when comparing with control. PEBP-1 S-
nitrosylation also significantly increased 1 day after KA treatment
(173.9 ± 16.3%, p < 0.01, Fig. 4B). After 2, 3 and 5 days of treat-
ment, PEBP-1 S-nitrosylation was maintained, compared to control. S-
nitrosylation of PCNA and EF-1β was not observed in samples of DG,
using up to 1 mg of protein in cell lysate.
In order to evaluate the S-nitrosylation of these proteins in stem
cells of the DG, we exposed hippocampal stem cells to different con-
centrations of CysSNO (10, 50 and 100 μM) for 15 min and analyzed S-
nitrosylation by ascorbate-reducing biotin switch. We observed S-ni-
trosylation of hnRNP K, PCNA, 14-3-3 ε, EF-1β and PEBP-1 (Fig. 5A).
hnRNP K S-nitrosylation showed a tendency to increase after treatment
with 10 (243.2 ± 77.2%, Fig. 5B) and 50 μM CysSNO
(294.0 ± 97.1%), and significantly increased after treatment with
100 μM CysSNO (487.9 ± 112.65%, p < 0.01). Treatment with
100 μM CysSNO significantly increased PCNA S-nitrosylation
(260.7 ± 85.9%, p < 0.05, Fig. 5B), while after treatment with 10
and 50 μM CysSNO S-nitrosylation was maintained, compared to con-
trol. S-nitrosylation of 14-3-3 ε showed a tendency to increase after
treatment with 10 (241.5 ± 44.1%, Fig. 5B) and 50 μM CysSNO
(256.7 ± 21.0%), and significantly increased after treatment with
100 μM CysSNO (682.1 ± 209.3%, p < 0.05), when comparing with
control. S-nitrosylation of EF-1β was maintained after treatment with
10 μM CysSNO, and significantly increased after treatment with 50
(256.1% ± 34.6, p < 0.01, Figs. 5B) and 100 μM CysSNO
(234.2% ± 34.4, p < 0.05), when comparing with control. PEBP-1 S-
nitrosylation was maintained after treatment with 10 μM CysSNO but
showed a tendency to increase after treatment with 50 μM CysSNO
Table 2
Qualitative analysis of proteins differentially oxidized in NSC exposed to CysSNO.
Protein Spots in Control gelsa Spots in CysSNO gelsa Minimal Ratiob Oxidized Cys
EF-1β – Elongation factor-1β 1 7 3.2
14-3-3 ε 3 7 3.8 97, 98
14-3-3 θ 2 6 2.1 25, 94, 134
14-3-3 ζ/δ 0 8 25, 94
PCNA – Proliferating cell nuclear antigen 1 6 2.4
Secernin-1 1 4 2.1
HSPA4 – Heat shock 70 kDa protein 4 0 2
TER ATPase – Transitional endoplasmic reticulum ATPase 2 8 3.7 105, 522, 535
hnRNP K – Heterogeneous nuclear ribonucleoprotein K 0 4 145
a Number of replicates in which the spot is detected.
b Minimal value obtained for the ratio (RFS signal in CysSNO/RFS signal in Control) of replicate(s) in which a spot was found in Control.
Table 3
Quantitative analysis of proteins differentially oxidized in NSC exposed to CysSNO.
Protein Spots in Control gelsa Spots in CysSNO gelsa Mean ratio± sdb t-test p value Oxidized Cys
PEBP-1 – Phosphatidylethanolamine-binding protein 3 7 2.4 ± 0.7 0.006
hnRNP H – Heterogeneous nuclear ribonucleoprotein H 6 7 3.4 ± 2.0 0.001
a Number of replicates in which the spot is detected.
b Mean ± standard deviation of the ratios (RFS signal in CysSNO/RFS signal in Control) in individual experiments.
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(204.3 ± 73.7%, Fig. 5B) and significantly increased with 100 μM
CysSNO treatment (339.9 ± 100.0%, p < 0.05), when comparing
with control.
4. Discussion
NO is a signaling molecule with several functions in the organism.
Through S-nitrosylation, NO can modify the function of proteins re-
levant for many processes. As an important regulator of adult en-
dogenous neurogenesis, NO is able to increase NSC proliferation after
brain injury. However, this repair process is far from effective. The
identification of proteins that could contribute to improve its outcome
is therefore of particular importance. The goal of this work was to
identify S-nitrosylation targets of NO that could be involved in neuro-
genesis, in NSC. Using complementary techniques of thiol redox pro-
teomics to screen for possible targets, twelve proteins oxidized in SVZ-
derived NSC after exposure to CysSNO were identified. We further in-
vestigated the oxidation and S-nitrosylation status of some of these
proteins in both SVZ- and DG-derived NSC, and in the DG after seizures.
A group of proteins S-nitrosylated by NO in NSC was identified: hnRNP
K, PCNA, 14-3-3,14-3-3 ε, EF-1β and PEBP-1. Indeed, S-nitrosylation of
several of them has been confirmed in a murine model of injury-in-
duced neurogenesis, at different time points.
The identified proteins have different functions, but most are related
to cell proliferation. 14-3-3 proteins are a family of adaptor proteins
that regulate cell signaling pathways. They can activate the ERK/MAPK
pathway, which is involved in the proliferative effect of NO in NSC
[23], by interacting with c-Raf [46,47]. The isoform 14-3-3 ε has an
important role in neurogenesis and neuronal migration [48], and has
been described to be S-nitrosylated in mesangial cells [49] and in pri-
mary ovine fetoplacental artery endothelial cells [50]. PEBP-1 also
regulates the ERK/MAPK pathway, preventing MEK phosphorylation by
binding to c-Raf [51], and it increases neuronal differentiation, both in
a human neuroblastoma cell line [52] and in adult rat hippocampal
progenitor cells [53]. PEBP-1 is regulated by phosphorylation [54], and
S-nitrosylation of its Cys168 has been described in SH-SY5Y cells
treated with CysSNO [55]. PCNA is necessary for DNA replication and
is, therefore, essential for cell proliferation. In response to epidermal
growth factor receptor signaling, which is involved in NSC proliferation
[56], PCNA is phosphorylated and protected from degradation [57].
PCNA can be S-nitrosylated in Cys81 [58], which blocks its interaction
with caspase-9 and promotes apoptosis in a human neuroblastoma cell
line [59]. hnRNP K belongs to a family of proteins that bind RNA and
are involved in nucleic acid metabolism [60]. hnRNP K is essential for
axonogenesis in Xenopus [61] and its inactivation, coupled with acti-
vation of the neuronal Hu-p21 pathway, may be essential to the switch
from proliferation to differentiation in NSC [62]. The activity of hnRNP
K is regulated by several PTM (reviewed in Ref. [63]), but S-ni-
trosylation is still yet to be described. EF-1α and EF-1β are part of the
elongation factor 1 complex, which is responsible for translation elon-
gation. EF-1α delivers aa-tRNAs to the A site of the ribosome [64] and
EF-1β replaces EF-1α-bound GDP for GTP [65]. EF-1β and its regulation
are essential for the function of EF-1α. Although a role in neurogenesis
is not described, EF-1α can interact with and regulate Akt [66,67], a
pathway involved in the proliferation of NSC [68,69]. EF-1β can be
regulated by phosphorylation [70], but its S-nitrosylation has not been
described.
Overall, we confirmed the S-nitrosylation of 14-3-3, specifically of
14-3-3 ε, and PCNA. Moreover, as far as we known, we are the first to
describe the S-nitrosylation of PEBP-1, hnRNP K and EF-1β. We also
identified Cys97 and Cys98 as potential S-nitrosylation sites for 14-3-3
ε, and Cys145 as the S-nitrosylation site for hnRNP K.
Fig. 2. Differentially oxidized proteins fol-
lowing treatment with CysSNO. Representative
2_DE gel of sample treated with 100 μM CysSNO
for 15 min stained with Sypro Ruby, showing the
protein identified in each spot. EF-1β, elongation
factor-1β; PCNA, proliferating cell nuclear an-
tigen; PEBP-1, phosphatidylethanolamine-binding
protein; HSPA4, heat shock 70 kDa protein 4; TER
ATPase, transitional endoplasmic reticulum
ATPase; hnRNP K, Heterogeneous nuclear ribo-
nucleoprotein K; hnRNP H, Heterogeneous nuclear
ribonucleoprotein H.
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To validate the identified targets, we used a mouse model of ex-
citotoxic brain lesion that has increased proliferation in the dentate
gyrus following seizures [71], in a manner dependent on NO produced
by inducible NO synthase [23]. Transient S-nitrosylation of hnRNP K,
14-3-3,14-3-3 ε and PEBP-1 was detected in this model. S-nitrosylation
was present 1 day (14-3-3, 14-3-3 ε, PEBP-1) or 2 days (hnRNP K) after
the induction of epileptic seizures. This occurs before the onset of
proliferation of NSC in this model, which is observed 3 days after sei-
zures [23,25]. Therefore, it is possible that, through regulation by NO
from inflammatory origin, these proteins can contribute for the process
of neurogenesis in this model, especially in proliferation. The fact that
S-nitrosylation was observed at different times after seizures may be
related to the different functions of these proteins. 14-3-3 proteins seem
to have an important role in excitotoxicity. In rat hippocampus, 4 h
following KA-induced excitotoxicity, the levels of total 14-3-3 are re-
duced [72]. This decrease is isoform-selective and dependent on loca-
lization, with 14-3-3 γ and 14-3-3 δ levels being decreased in micro-
some-enriched fractions [73]. A reduction in 14-3-3 protein levels has
also been found in rat frontal cortex 24 h after KA treatment, with 14-3-
3 γ, 14-3-3 ε, 14-3-3 η and 14-3-3 τ levels being decreased. This effect is
accompanied by an increase in ERK phosphorylation levels [74], which
is necessary for NSC proliferation. The decrease in 14-3-3 isoforms le-
vels in certain cellular compartments after KA-induced excitotoxicity
may be due to degradation by proteolysis [75]. However, it is probable
that in others, such as the cytoplasm, regulation of 14-3-3 isoforms may
occur through PTM, namely S-nitrosylation. Both 14-3-3 proteins and
PEBP-1 regulate the ERK/MAPK pathway and are rapidly S-nitrosylated
following seizures. In a previous work, we observed that Ras is S-ni-
trosylated 2 days after seizures [28], which suggests that, before acting
directly on components of the ERK/MAPK pathway, NO reacts with
regulators of this signaling pathway. hnRNP K is a substrate of ERK1/2,
being accumulated in the cytoplasm upon phosphorylation by this ki-
nase [76]. Thus, it is not surprising that it is S-nitrosylated in a later
time point than regulators of the ERK/MAPK pathway. In summary, it is
possible that NO first S-nitrosylates PEBP-1 and 14-3-3 proteins, re-
leasing the inhibitory effect of PEBP-1 and promoting the activating
effect of 14-3-3 in c-Raf, followed by S-nitrosylation of members of the
ERK/MAPK pathway (namely Ras) and of downstream proteins, such as
hnRNP K. Although S-nitrosylation of PCNA and EF-1β was not detected
in this model, their regulation by S-nitrosylation in other models of
neurogenesis is not excluded.
To evaluate S-nitrosylation of the identified targets in DG stem cells,
we treated hippocampal stem cells with different concentrations of
CysSNO. S-nitrosylation of all the identified proteins was detected in a
dose-dependent manner, with higher levels as the concentration of
CysSNO increased. The range of CysSNO concentrations used in this
study included positive and negative effects on cell proliferation.
Treatment with the lowest concentrations of CysSNO (10 and 50 μM)
for 1 h enhances the proliferation of SVZ-derived NSC, while treatment
with the highest concentration of CysSNO (100 μM) inhibits this process
(Ana I. Santos and Inês Araújo, data not shown). Interestingly, the
proteins that were S-nitrosylated in the in vivo model showed a ten-
dency to be S-nitrosylated by CysSNO at the proliferative concentra-
tions. Moreover, the proteins whose S-nitrosylation was not detectable
in the in vivo model showed lower levels of S-nitrosylation, even at the
highest CysSNO concentration used, despite being S-nitrosylated by
CysSNO in SVZ-derived NSC. This further indicates a possible physio-
logical relevance of the identified proteins for hippocampal neurogen-
esis.
The roles of the new identified targets of NO in neurogenesis
Fig. 3. Treatment of SVZ-derived NSC with CysSNO induces oxidation, including S-nitrosylation, of proteins. Oxidation (A) and S-nitrosylation (B) of hnRNP
K, PCNA, 14-3-3 proteins, EF-1β, PEBP-1, HSPA4 and hnRNP H was assessed by DTT-reducing (A) and ascorbate-reducing (B) biotin switch assays.
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deserve further investigation. Using S-nitrosylation insensitive mutant
proteins with cysteines replaced by other amino acids, the functions of
these S-nitrosylation targets can now be investigated on several pro-
cesses related to neurogenesis.
5. Conclusion
This work allowed the identification of several proteins as targets of
S-nitrosylation in NSC and in a murine model of injury-induced neu-
rogenesis. While some were already known to be S-nitrosylated, S-ni-
trosylation of others was observed for the first time (hnRNP K, 14-3-3 ε,
and PEBP-1). These targets may be candidates for NO-induced regula-
tion of neurogenesis in early stages of the formation of newborn
neurons after injury.
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